Brief: Enveric Biosciences Inc Completes Manufacturing Of Eb-373 To Supply Drug Material For Completion Of Preclinical Program
21/08/2023 13:18
Aug 21 (Reuters) -
* ENVERIC BIOSCIENCES INC - COMPLETES MANUFACTURING OF
EB-373 TO
SUPPLY DRUG MATERIAL FOR COMPLETION OF PRECLINICAL PROGRAM
* ENVERIC BIOSCIENCES INC - WILL IMMEDIATELY COMMENCE
REMAINING
GLP STUDIES TO PROVIDE CRITICAL DATA REQUIRED TO INITIATE HUMAN
TRIALS FOR EB-373
Source text for Eikon: ID:nBw3Ldsxja
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003